The Brain-Computer Interface Race

The boundary between science fiction and medical reality is rapidly dissolving. For millions of people suffering from paralysis due to spinal cord injuries or ALS, the development of Brain-Computer Interfaces (BCIs) offers something that was once impossible: the restoration of autonomy. While Elon Musk’s Neuralink grabs the headlines, a fierce competition involving companies like Synchron, Precision Neuroscience, and Blackrock Neurotech is driving the industry toward a singular goal. They are racing to create a device that not only controls computers but restores full physical mobility.

Neuralink’s "Telepathy" and Patient Milestones

Neuralink is currently the most visible player in this sector. Their flagship device, referred to as “Telepathy,” is designed to let users control a computer cursor or keyboard using only their thoughts. The technology involves a coin-sized chip, the N1, which is surgically embedded in the skull. A robotic system inserts 64 flexible threads containing 1,024 electrodes directly into the brain tissue to record neural activity.

The company achieved a massive breakthrough with its first human participant, Noland Arbaugh, in early 2024. Arbaugh, who is quadriplegic, demonstrated the ability to play video games like Civilization VI and Mario Kart and post on social media simply by thinking about moving a cursor.

In August 2024, Neuralink successfully implanted its device in a second participant named Alex. This second trial tested new mitigation strategies to prevent the thread retraction issues seen in the first patient. Alex was able to use CAD (computer-aided design) software to design a 3D mount for his charger and play the game Counter-Strike 2. These trials are part of the PRIME Study, an investigational medical device trial approved by the FDA to evaluate safety and initial functionality.

The Major Competitor: Synchron

While Neuralink requires removing a piece of the skull for implantation, its main rival, Synchron, takes a different approach. Synchron focuses on endovascular BCI technology. Their device, the Stentrode, does not require open-brain surgery. Instead, it is inserted through the jugular vein and guided up a blood vessel until it sits next to the motor cortex of the brain.

Because this procedure is less invasive, Synchron has been able to move quickly through early clinical stages. As of mid-2024, they have implanted their device in over 10 patients across the United States and Australia.

Synchron is also focusing heavily on consumer integration. They recently announced compatibility with the Apple Vision Pro headset. This integration allows patients to control the headset’s eye-tracking selection tools with their thoughts. This allows for hands-free texting, emailing, and web browsing without the risks associated with drilling into the skull.

Precision Neuroscience and the "Layer 7" Approach

Another key player is Precision Neuroscience, co-founded by Benjamin Rapoport, a former founding member of Neuralink. Precision aims to bridge the gap between high performance and safety. Their flagship product is the Layer 7 Cortical Interface.

The Layer 7 is a flexible, ultra-thin film (thinner than a human hair) containing 1,024 electrodes. Unlike Neuralink, which penetrates the brain tissue, the Layer 7 sits on top of the cerebral cortex. It is inserted through a very small slit in the skull, a procedure the company describes as “minimally traumatic.”

This design aims to provide the high-resolution data needed for complex movement without damaging brain tissue. In 2024, the company set a record for the number of electrodes placed on a human brain during a temporary procedure, gathering crucial data on how the brain maps finger movements.

From Cursors to Full Mobility

The snippet provided emphasizes the goal of restoring “full mobility.” Controlling a mouse cursor is step one. Step two is the “digital bridge.”

To make a paralyzed person walk again, the BCI must bypass the injured spinal cord entirely. The brain signal is captured by the implant, decoded by a computer, and then sent wirelessly to a stimulator implanted on the spinal cord below the injury.

This is not theoretical. Researchers in Switzerland, using technology similar to what commercial companies are developing, successfully created a “digital bridge” for Gert-Jan Oskam. Oskam, paralyzed in a cycling accident, was able to stand and walk naturally by thinking about it. The bridge reconnected his brain to his legs.

Neuralink has stated that after “Telepathy,” their next major product is “Blindsight” (for vision restoration), followed by technologies specifically aimed at bridging spinal cord injuries to restore motor function to limbs.

Challenges to Widespread Adoption

Despite the excitement, several hurdles remain before these devices become standard medical care:

Signal Stability: The brain is a hostile environment for electronics. Scar tissue can form around electrodes (gliosis), degrading the signal quality over time.
Battery and Heat: Implants need power. Neuralink charges wirelessly, but managing the heat generated by the battery and chip is critical to prevent tissue damage.
Hardware Longevity: These devices need to last for decades. Current trials are testing durability, but long-term data (10+ years) simply does not exist yet.
FDA Approval: All current procedures are under Investigational Device Exemptions (IDE). Full FDA market approval is likely years away.

The Future of BCI

The market is moving fast. Blackrock Neurotech, a veteran in the space known for the “Utah Array,” was acquired by Tether in 2024 to accelerate commercialization. With billions of dollars in investment flowing into Neuralink, Synchron, and Precision, the race is no longer just about reading brain waves. It is about manufacturing independence for those who have lost it.

Frequently Asked Questions

How much will a BCI implant cost? While currently available only through funded clinical trials at no cost to the patient, experts estimate the early commercial price could range between $40,000 and $50,000, comparable to a pacemaker or cochlear implant, eventually dropping as the technology matures.

Does the surgery hurt? The brain itself has no pain receptors. While the incision in the scalp requires anesthesia and recovery time, the implantation of electrodes into the brain tissue is painless.

Can healthy people get a Neuralink? Not currently. The FDA has only authorized trials for patients with severe physical impairments, such as quadriplegia or ALS. Consumer applications for memory enhancement or gaming for healthy individuals are hypothetical and likely decades away.

What happens if the company goes out of business? This is a significant ethical concern. Patients rely on proprietary software and hardware support. Regulators and bioethicists are currently debating requirements for “technological continuity” to ensure patients are not left with unsupported hardware in their bodies.